GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tong Ren Tang Technologies Co Ltd (HKSE:01666) » Definitions » 3-Year EPS without NRI Growth Rate

Tong Ren Tang Technologies Co (HKSE:01666) 3-Year EPS without NRI Growth Rate : 4.20% (As of Dec. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Tong Ren Tang Technologies Co 3-Year EPS without NRI Growth Rate?

Tong Ren Tang Technologies Co's EPS without NRI for the six months ended in Dec. 2023 was HK$0.20.

During the past 12 months, Tong Ren Tang Technologies Co's average EPS without NRI Growth Rate was 2.40% per year. During the past 3 years, the average EPS without NRI Growth Rate was 4.20% per year. During the past 5 years, the average EPS without NRI Growth Rate was 0.30% per year. During the past 10 years, the average EPS without NRI Growth Rate was 0.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Tong Ren Tang Technologies Co was 32.20% per year. The lowest was -10.30% per year. And the median was 10.35% per year.


Competitive Comparison of Tong Ren Tang Technologies Co's 3-Year EPS without NRI Growth Rate

For the Drug Manufacturers - General subindustry, Tong Ren Tang Technologies Co's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tong Ren Tang Technologies Co's 3-Year EPS without NRI Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tong Ren Tang Technologies Co's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Tong Ren Tang Technologies Co's 3-Year EPS without NRI Growth Rate falls into.



Tong Ren Tang Technologies Co 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Tong Ren Tang Technologies Co  (HKSE:01666) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Tong Ren Tang Technologies Co 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Tong Ren Tang Technologies Co's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Tong Ren Tang Technologies Co (HKSE:01666) Business Description

Traded in Other Exchanges
Address
No. 16 Tongji Beilu, Beijing Economic and Technological Development Zone, Beijing, CHN
Tong Ren Tang Technologies Co Ltd is engaged in the production and distribution of Chinese medicine and primarily operates in Mainland China and Hong Kong. The operating segments derive their revenue primarily from the manufacture and sale of Chinese medicine of the company in Mainland China and Tong Ren Tang Chinese Medicine and its subsidiaries engaged in manufacturing, retail, and wholesale of Chinese medicine products and healthcare products, and provision of Chinese medical consultation and treatments outside Mainland China and wholesale of healthcare products in Mainland China.

Tong Ren Tang Technologies Co (HKSE:01666) Headlines

No Headlines